ArticleAnnals of surgical oncology2023

Great Debates: Neoadjuvant Therapy Should be Routinely Given for High-Risk Cholangiocarcinoma.

Hop S Tran Cao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.